# BCG Re-vaccination for Primary Tuberculosis Prophylaxis in the Prison Population

> **NCT05541952** · PHASE4 · WITHDRAWN · sponsor: **Federal University of Mato Grosso**

## Conditions studied

- Latent Tuberculosis

## Interventions

- **BIOLOGICAL:** BCG

## Key facts

- **NCT ID:** NCT05541952
- **Lead sponsor:** Federal University of Mato Grosso
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2020-08-17
- **Primary completion:** 2020-08-17
- **Final completion:** 2020-08-17
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** New evidence points to a new candidate vaccine, with a superior trial to BCG.
- **Last updated:** 2023-10-19

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05541952

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05541952, "BCG Re-vaccination for Primary Tuberculosis Prophylaxis in the Prison Population". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT05541952. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*